ESTRONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Estrone, and what generic alternatives are available?
Estrone is a drug marketed by Dr Reddys and Watson Labs and is included in two NDAs.
The generic ingredient in ESTRONE is estrone. There are nine drug master file entries for this compound. Additional details are available on the estrone profile page.
Summary for ESTRONE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 106 |
| Clinical Trials: | 46 |
| Patent Applications: | 3,565 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ESTRONE at DailyMed |
Recent Clinical Trials for ESTRONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Maryland, Baltimore | Early Phase 1 |
| InnovaGyn, Inc. | Phase 2 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 2 |
Medical Subject Heading (MeSH) Categories for ESTRONE
Anatomical Therapeutic Chemical (ATC) Classes for ESTRONE
US Patents and Regulatory Information for ESTRONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys | ESTRONE | estrone | INJECTABLE;INJECTION | 085239-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Watson Labs | ESTRONE | estrone | INJECTABLE;INJECTION | 083397-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
